Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Does O-GlcNAc play a role in neurodegenerative diseases?

Lefebvre T, Guinez C, Dehennaut V, Beseme-Dekeyser O, Morelle W, Michalski JC.

Expert Rev Proteomics. 2005 Apr;2(2):265-75. Review.

PMID:
15892570
2.

Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.

Vosseller K, Wells L, Hart GW.

Biochimie. 2001 Jul;83(7):575-81. Review.

PMID:
11522385
4.

The role of O-linked protein glycosylation in beta-cell dysfunction.

Konrad RJ, Kudlow JE.

Int J Mol Med. 2002 Nov;10(5):535-9. Review.

PMID:
12373287
6.

Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.

Wells L, Vosseller K, Hart GW.

Science. 2001 Mar 23;291(5512):2376-8. Review.

PMID:
11269319
8.
9.

Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification.

Vosseller K, Sakabe K, Wells L, Hart GW.

Curr Opin Chem Biol. 2002 Dec;6(6):851-7. Review.

PMID:
12470741
10.

The hexosamine signaling pathway: deciphering the "O-GlcNAc code".

Love DC, Hanover JA.

Sci STKE. 2005 Nov 29;2005(312):re13. Review.

PMID:
16317114
11.

O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.

Butkinaree C, Park K, Hart GW.

Biochim Biophys Acta. 2010 Feb;1800(2):96-106. doi: 10.1016/j.bbagen.2009.07.018. Epub 2009 Aug 6. Review.

12.

[Role of O-GlcNAc modification of cellular proteins in signal transduction].

KrzeĊ›lak A.

Postepy Biochem. 2007;53(4):389-99. Review. Polish.

PMID:
19024903
13.

O-GlcNAc modification, insulin signaling and diabetic complications.

Issad T, Masson E, Pagesy P.

Diabetes Metab. 2010 Dec;36(6 Pt 1):423-35. doi: 10.1016/j.diabet.2010.09.001. Epub 2010 Nov 11. Review.

PMID:
21074472
14.

O-GlcNAc: a regulatory post-translational modification.

Wells L, Whelan SA, Hart GW.

Biochem Biophys Res Commun. 2003 Mar 14;302(3):435-41. Review.

PMID:
12615051
15.

O-GlcNAc modification in diabetes and Alzheimer's disease.

Dias WB, Hart GW.

Mol Biosyst. 2007 Nov;3(11):766-72. Epub 2007 Aug 29. Review.

PMID:
17940659
16.

Nucleoplasmic and cytoplasmic glycoproteins.

Hart GW, Haltiwanger RS, Holt GD, Kelly WG.

Ciba Found Symp. 1989;145:102-12, discussion 112-8. Review.

PMID:
2507249
17.

O-GlcNAc glycosylation: a signal for the nuclear transport of cytosolic proteins?

Guinez C, Morelle W, Michalski JC, Lefebvre T.

Int J Biochem Cell Biol. 2005 Apr;37(4):765-74. Review.

PMID:
15694836
18.

O-GlcNAcylation, an original modulator of contractile activity in striated muscle.

Cieniewski-Bernard C, Montel V, Stevens L, Bastide B.

J Muscle Res Cell Motil. 2009 Dec;30(7-8):281-7. doi: 10.1007/s10974-010-9201-1. Epub 2010 Feb 25. Review.

PMID:
20182775
19.

Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.

Hart GW, Housley MP, Slawson C.

Nature. 2007 Apr 26;446(7139):1017-22. Review.

PMID:
17460662
20.

Glycan-dependent signaling: O-linked N-acetylglucosamine.

Hanover JA.

FASEB J. 2001 Sep;15(11):1865-76. Review.

PMID:
11532966

Supplemental Content

Support Center